enquirer.com

News
Front Page
Local
Sports
-Bengals
-Reds
-Bearcats
-Xavier
Business
Health
Technology
Weather
Traffic
Back Issues
Photographs
AP Wire
-World
-Nation
-Sports
-Business
-Arts
-Health

Classifieds
Jobs
Autos
General
Obits
Homes

Freetime
Movies
Dining
Calendars
Weekend

Opinion
Columns
Borgman

GoCinci
HelpDesk
Feedback
Circulation
Subscribe
Phone #'s
Search

E N Q U I R E R   L O C A L   N E W S   C O V E R A G E
Wednesday, May 03, 2000

Funds found for more tests of company's artificial blood


Products based on local researcher's work

By Tim Bonfield
The Cincinnati Enquirer

        KETTERING, Ohio — Synthetic Blood International Inc., announced that it has raised the final installment of $5.5 million in private investment to continue its testing of three products: a type of blood substitute, a liquid breathing product, and an implantable glucose sensor for diabetics.

        The company also said this week that it has started acute toxicity studies on its Oxycyte substitute blood product. By year's end, it plans to begin animal studies on Fluorovent, the liquid breathing product, and the glucose sensor.

        All three products are based largely on the work of Dr. Leland Clark, a medical researcher who lives in Clifton and serves as a research consultant for the company.

        Given the sporadic but increasing supply shortfalls reported by blood banks in Cincinnati and nationwide, several organizations have been racing to develop artificial blood.

        Synthetic Blood International officials say their blood substitute is different from HemAssist, a Baxter International Inc. product. Human testing of HemAssist was halted in 1998 after initial results from 100 severely injured trauma patients resulted in more deaths than expected.

        Dr. Clark's breathable liquid was featured in the movie The Abyss, which portrayed deep sea divers breathing his liquid instead of oxygen gas.

        In 1951, while at Children's Hospital Medical Center, Dr. Clark invented the first practical heart-lung machine, which made open-heart surgery possible.

        While headquartered in Kettering, most of the company's product testing has been done in Newport Beach, Calif.

       



37 years after cheerleader's death, boyfriend charged
Students take byte out of life with computers
Dental board to face charges in hearings
RADEL: Motto makers
Alliance seeks new blood
   Resignation signals change for hospitals
    The evolution of an alliance
KIESEWETTER: Two anchors are sinking newscasts
Around The Commonwealth
A.M. REPORT
Bill on evolution returns
Carlisle has plans for land
Council may pull housing funding
Flower Show goes beyond blooms with kids, sports displays
- Funds found for more tests of company's artificial blood
Get to it
Here are terms to increase enjoyment of Kentucky Derby
Jets cost thousands an hour
Lawyer wants taped confession tossed
Man charged with trying to set wife on fire
Math teacher recognized nationally
Milford man to address Methodists today
Pig Gig: All Earth Mother wants is a little respect
Police: Boy, 13, took unloaded gun to New Richmond High
Proposal to restore CSX station renewed
Siren rules not uniform
Teachers to vote on staff changes
Turnout a whisper in Indiana
Veterans build home to help sick comrades
Yankee Grey: A band on the way
CROWLEY: Kentucky politics
Queen City's moments to shine reflected in book


 
Search | Questions/help | News tips | Letters to the editors
Web advertising | Place a classified | Subscribe | Circulation

Copyright 1995-2000. The Cincinnati Enquirer, a Gannett Co. Inc. newspaper.
Use of this site signifies agreement to terms of service updated 4/5/2000.